NCT01515787 2024-02-02
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Phase 2/3 Unknown
Clinical Trials
14 trialsNCT05409417 2022-06-08
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT05253066 2022-02-23
Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer
Shengjing Hospital
Phase 2/3 Unknown
NCT05209256 2022-01-26
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2/3 Unknown
NCT03008148 2021-05-11
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Johnpro Biotech, Inc.
Phase 2/3 Unknown
NCT02856048 2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Unknown
NCT02451774 2018-05-09
PTX-II
University of Guadalajara
Phase 2/3 Unknown
NCT03399253 2018-01-16
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
Sun Yat-sen University
Phase 2/3 Unknown
NCT03344068 2017-12-22
Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2/3 Unknown
NCT02606539 2017-03-22
SVCGTN
Mansoura University
Phase 2/3 Unknown
NCT02240771 2014-09-16
Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT01438450 2012-07-13
OTCHCC
All India Institute of Medical Sciences
Phase 2/3 Unknown
NCT01402180 2011-07-26
Nimotuzumab
Fudan University
Phase 2/3 Unknown